• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

45
43
43
36
31

COUNTRY

19
18
14
11
1

CATEGORIES

  • 75
  • 33
  • 23
  • 13
  • 9
  • 9
  • 8
  • 6
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

82
124
129
184

PUBLISHED

6
6
15
184

PRODUCT TYPE

141
21
20
1
1

Search "Nail Therapies" returned 184 results.

Cell Therapy - Technologies, Markets and Companies Cell Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Cell Therapy - Technologies, Markets and Companies

This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. Hematopoietic stem cell transplantation is...

August 2015
FROM

Ketoconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022

Ketoconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Ketoconazole (Dermatophytic Onychomycosis)...

June 2013
FROM

Terbinafine (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022

Terbinafine (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Terbinafine (Dermatophytic Onychomycosis)...

June 2013
FROM

Tavaborole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022

Tavaborole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tavaborole (Dermatophytic Onychomycosis)...

June 2013
FROM

Luliconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022

Luliconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Luliconazole (Dermatophytic Onychomycosis)...

June 2013
FROM

Ciclopirox (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022

Ciclopirox (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Ciclopirox (Dermatophytic Onychomycosis)...

June 2013
FROM

Itraconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022

Itraconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Itraconazole (Dermatophytic Onychomycosis)...

June 2013
FROM

Griseofulvin (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022

Griseofulvin (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Griseofulvin (Dermatophytic Onychomycosis)...

June 2013
FROM

Fluconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022

Fluconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Fluconazole (Dermatophytic Onychomycosis)...

June 2013
FROM

TDT-067 (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022

TDT-067 (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “TDT-067 (Dermatophytic Onychomycosis) - Forecast...

June 2013
FROM

Efinaconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022

Efinaconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Efinaconazole (Dermatophytic Onychomycosis)...

June 2013
FROM

Albaconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022

Albaconazole (Dermatophytic Onychomycosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Albaconazole (Dermatophytic Onychomycosis)...

June 2013
FROM

Global Dermatophytic Onychomycosis Therapeutics Market 2012-2016

The analysts forecast the Global Dermatophytic Onychomycosis Therapeutics market to grow at a CAGR of 7.28 percent over the period 2012-2016. One of the key factors contributing to this market growth...

September 2013
FROM

United States Market for Psoriatic Arthritis Pharmacotherapy

This research service covers the United States psoriatic arthritis pharmaceuticals market from 2009 to 2017, with 2011 as the base year The focus of this study is prescription therapeutics prescribed...

July 2012
FROM
Transdermal Drug Delivery - Technologies, Markets, and Companies Transdermal Drug Delivery - Technologies, Markets, and Companies - Product Thumbnail Image

Transdermal Drug Delivery - Technologies, Markets, and Companies

This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, subcutaneous and transmucosal routes....

August 2015
FROM

PharmaPoint: Dermatophytic Onychomycosis (DO) - US Drug Forecast and Market Analysis to 2022

PharmaPoint: Dermatophytic Onychomycosis (DO) - US Drug Forecast and Market Analysis to 2022 Summary Dermatophytic onychomycosis (DO) is characterized as being a fungal infection of the nail. Infection...

June 2013
FROM

Erchonia Corporation - Product Pipeline Analysis, 2013 Update

Summary Erchonia Corporation (Erchonia) is a medical device manufacturer. The company conducts research, development, and manufacturing of medical laser and cosmetic laser products. Its products include...

December 2013
FROM

Dermatologic Principles and Practice in Oncology. Conditions of the Skin, Hair, and Nails in Cancer Patients

The first book focusing specifically on frequent and frequently disabling side effects involving the skin, hair and nails in cancer patients According to the World Health Organization, there are...

January 2014

Erchonia Corporation - Product Pipeline Analysis

Summary Erchonia Corporation (Erchonia) is a medical device company. The company’s product portfolio includes lasers, stands, percussor and adjustor. Erchonia's 3LT low level laser therapy comprises...

December 2012
FROM

04- 2012 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

This report includes details on 37 emerging medical technology companies that have been identified by LSI's in-house research team in April 2012. All companies include technology, market(s), key executive,...

April 2012
FROM
Loading Indicator

Our Clients

Ikea Systems B.V. GlaxoSmithKline PLC BT Group PLC. Philips N.V. BSH Home Appliances Ltd Foreign & Commonwealth Office